Back to results
US 12,491,266 B2Granted
Recombinant AAV vectors for treating glutaric aciduria type I
AssigneeShanghai Vitalgen Biopharma Co., Ltd.
InventorsLu Guo, Xi Zhu, Shin-Shay Tian, Xiaoping Zhao
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to codon-optimized sequences coding for hGCDH polypeptide and recombinant adeno-associated virus (rAAV) vectors comprising one of said sequences under the control of a promoter component. Also provided herein are viral particles comprising the rAAV vector, a pharmaceutical composition comprising the rAAV vector or the viral particles, and uses thereof in treating Glutaric aciduria type I (GA-I).
Claims12
An expression cassette comprising an isolated nucleic acid molecule and a promoter component,
- wherein the isolated nucleic acid molecule comprises a nucleotide sequence selected from a group of sequences consisting of SEQ ID NOs:
- 11-18, wherein the nucleotide sequence encodes human glutaryl-CoA dehydrogenase (hGCDH) polypeptide having an amino acid sequence as shown in SEQ ID NO:
- 33,
- wherein the promoter component is operatively linked to the 5′ of the nucleotide sequence encoding the hGCDH polypeptide,
- wherein the promoter component comprises
- (a) a constitutive promoter, and
- (b) one of the followings:
- (b1) an enhancer and an intron-derived fragment, or
- (b2) an intron-derived fragment;
- wherein the intron-derived fragment originates from the intron of SV40, or consists of one or more fragments derived from one or more intronic regions of the human GCDH gene, or is a hybrid intron
- wherein the intron-derived fragment has a nucleotide sequence as shown in any of SEQ ID NO:
- 27, SEQ ID NO:
- 28, SEQ ID NO:
- 30, SEQ ID NO:
- 31 or SEQ ID NO:
- 32.
13 more elements
Dependencies are inferred from the claim text.